Wound healing effects of nanoemulsion containing clove essential oil
Source abstract
Abstract
The aim of this study was to investigate the wound healing effects of clove oil (CO) via its encapsulation into nanoemulsion. Optimized nanoemulsion (droplet size of 29.10 nm) was selected for wound healing investigation, collagen determination, and histopathological examination in rats. Optimized nanoemulsion presented significant would healing effects in rats as compared to pure CO. Nanoemulsion also presented significant enhancement in leucine content (0.61 mg/g) as compared to pure CO (0.50 mg/g) and negative control (0.31 mg/g). Histopathology of nanoemulsion treated rats showed no signs of inflammatory cells. These results suggested that nanoemulsion of CO was safe and nontoxic.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Essential Oils and Antimicrobial Activity · Bee Products Chemical Analysis · Wound Healing and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia;
Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia;
Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;
Center of Excellence in Biotechnology Research (CEBR), King Saud University, Riyadh, Saudi Arabia
References (37)
Show source-provided references
1. 10.1002/ffj.202410.1002/ffj.2024 ↗
2. 10.5650/jos.ess1321310.5650/jos.ess13213 ↗
3. 10.1016/j.fct.2007.09.10610.1016/j.fct.2007.09.106 ↗
4. 10.1021/np960451q10.1021/np960451q ↗
5. 10.1016/j.jep.2012.08.03010.1016/j.jep.2012.08.030 ↗
6. 10.1002/ptr.212410.1002/ptr.2124 ↗
7. 10.1002/ptr.152810.1002/ptr.1528 ↗
8. 10.4315/0362-028X-66.3.39010.4315/0362-028X-66.3.390 ↗
9. Dash GK · J Nat Remed · 2001 · 1 · 105
10. Dwivedi V · J Pharmacog Phytochem · 2014 · 3 · 93
11. 10.1080/0148054090286223610.1080/01480540902862236 ↗
12. Farhapour MR · Vet Med · 2012 · 5310.17221/4972-VETMED ↗
13. 10.4315/0362-028X-65.10.154510.4315/0362-028X-65.10.1545 ↗
14. 10.1002/ptr.217910.1002/ptr.2179 ↗
15. 10.1186/s12906-015-0813-210.1186/s12906-015-0813-2 ↗
16. 10.1016/S0367-326X(02)00315-510.1016/S0367-326X(02)00315-5 ↗
17. 10.3109/1388020090357875410.3109/13880200903578754 ↗
18. 10.2174/092986703345771910.2174/0929867033457719 ↗
19. 10.3109/21691401.2014.88701810.3109/21691401.2014.887018 ↗
20. 10.1172/JCI10286110.1172/JCI102861 ↗
21. 10.1021/jf010346910.1021/jf0103469 ↗
22. Moore S · J Biol Chem · 1948 · 176 · 36710.1016/S0021-9258(18)51034-6 ↗
23. Obitte NC · J Pharm · 2014 · E340486
24. 10.1248/cpb.48.146710.1248/cpb.48.1467 ↗
25. 10.1080/10412905.2012.65952810.1080/10412905.2012.659528 ↗
26. 10.1080/0193269080264401210.1080/01932690802644012 ↗
27. 10.3109/1083745090296795410.3109/10837450902967954 ↗
28. 10.1016/j.colsurfb.2009.09.01010.1016/j.colsurfb.2009.09.010 ↗
29. 10.2174/15734131079094574010.2174/157341310790945740 ↗
30. 10.3109/21691401.2014.96619210.3109/21691401.2014.966192 ↗
31. 10.1080/10412905.2013.82067210.1080/10412905.2013.820672 ↗
32. 10.1016/j.jconrel.2012.02.02710.1016/j.jconrel.2012.02.027 ↗
33. Tumen I · Evi Based Compl Alter Med · 2012 · E788281
34. 10.1089/jmf.2012.247210.1089/jmf.2012.2472 ↗
35. 10.1111/1523-1747.ep1239556410.1111/1523-1747.ep12395564 ↗
36. 10.3109/21691401.2013.84556910.3109/21691401.2013.845569 ↗
37. 10.1021/np50085a02910.1021/np50085a029 ↗